Source link : https://newshealth.biz/health-news/polatuzumab-vedotin-with-r-chp-shows-strong-activity-in-older-dlbcl-patients/
(MedPage Today) — At the recent American Society of Hematology (ASH) annual meeting, a multicenter retrospective analysis used real-world data to examine the use of polatuzumab vedotin (Polivy) with rituximab, cyclophosphamide, doxorubicin, prednisone… Source link : https://www.medpagetoday.com/meetingcoverage/ashfuturefocusdlbcl/118911 Author : Publish date : 2025-12-09 17:52:00 Copyright for syndicated content belongs to the linked Source.
The post Polatuzumab Vedotin With R-CHP Shows Strong Activity in Older DLBCL Patients first appeared on News Health.
—-
Author : News Health
Publish date : 2025-12-09 17:52:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8